Importance of dihydropyrimidine dehydrogenase (DPD) deficiency in patients exhibiting toxicity following treatment with 5-fluorouracil
Authors:
- Robert B DiasioRDRobert B Diasio
- 1 May 2001
- journal article
- Published by Elsevier in Advances in Enzyme Regulation
- Vol. 41 (1) , 151-157
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Genotype and phenotype in patients with dihydropyrimidine dehydrogenase deficiencyHuman Genetics, 1999
- Dihydropyrimidine dehydrogenase deficiency and fluorouracil-related toxicityBritish Journal of Cancer, 1999
- Semi-automated radioassay for determination of dihydropyrimidine dehydrogenase (DPD) activity screening cancer patients for DPD deficiency, a condition associated with 5-fluorouracil toxicityJournal of Chromatography B: Biomedical Sciences and Applications, 1997
- Purification and characterization of dihydropyrimidine dehydrogenase from human liver.Journal of Biological Chemistry, 1992
- Familial deficiency of dihydropyrimidine dehydrogenase. Biochemical basis for familial pyrimidinemia and severe 5-fluorouracil-induced toxicity.Journal of Clinical Investigation, 1988